| Progressive Feet Llc | |
|
8565 Sudley Rd Ste B, Manassas, VA 20110-3864 | |
| (571) 428-2350 | |
| (571) 285-4240 |
| Full Name | Progressive Feet Llc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 8565 Sudley Rd Ste B, Manassas, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821770256 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | (* (Not Available)) | Primary |
| Provider Name | Christen Lonas |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1295756542 PECOS PAC ID: 8820279169 Enrollment ID: I20110221000401 |
News Archive
Many experts believe state-level health exchanges are here to stay. However, Politico reports that some state officials worry that if the individual mandate is struck down, healthy people could avoid buying policies and premiums for everyone else could skyrocket, putting them in a bind.
A growing risk of outbreaks of measles, pertussis, and other vaccine-preventable diseases in countries affected by Ebola must be countered by urgent scaling up of routine immunization activities, according to the World Health Organization.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
Researchers have developed a new analytical tool for medical applications and biological research that might be used to diagnose cancer more rapidly than conventional methods.
› Verified 4 days ago
| Provider Name | Arash Ari Changizi |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1487090494 PECOS PAC ID: 2668765215 Enrollment ID: I20200505002843 |
News Archive
Many experts believe state-level health exchanges are here to stay. However, Politico reports that some state officials worry that if the individual mandate is struck down, healthy people could avoid buying policies and premiums for everyone else could skyrocket, putting them in a bind.
A growing risk of outbreaks of measles, pertussis, and other vaccine-preventable diseases in countries affected by Ebola must be countered by urgent scaling up of routine immunization activities, according to the World Health Organization.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
Researchers have developed a new analytical tool for medical applications and biological research that might be used to diagnose cancer more rapidly than conventional methods.
› Verified 4 days ago
| Provider Name | Daniel Stevens |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1457858011 PECOS PAC ID: 5991040958 Enrollment ID: I20210708001416 |
News Archive
Many experts believe state-level health exchanges are here to stay. However, Politico reports that some state officials worry that if the individual mandate is struck down, healthy people could avoid buying policies and premiums for everyone else could skyrocket, putting them in a bind.
A growing risk of outbreaks of measles, pertussis, and other vaccine-preventable diseases in countries affected by Ebola must be countered by urgent scaling up of routine immunization activities, according to the World Health Organization.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
Researchers have developed a new analytical tool for medical applications and biological research that might be used to diagnose cancer more rapidly than conventional methods.
› Verified 4 days ago
| Provider Name | Amar Gulati |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1992200042 PECOS PAC ID: 7911395256 Enrollment ID: I20221116000255 |
News Archive
Many experts believe state-level health exchanges are here to stay. However, Politico reports that some state officials worry that if the individual mandate is struck down, healthy people could avoid buying policies and premiums for everyone else could skyrocket, putting them in a bind.
A growing risk of outbreaks of measles, pertussis, and other vaccine-preventable diseases in countries affected by Ebola must be countered by urgent scaling up of routine immunization activities, according to the World Health Organization.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
Researchers have developed a new analytical tool for medical applications and biological research that might be used to diagnose cancer more rapidly than conventional methods.
› Verified 4 days ago
| Provider Name | Hufsa Hussan |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1326562182 PECOS PAC ID: 2860809316 Enrollment ID: I20221213000593 |
News Archive
Many experts believe state-level health exchanges are here to stay. However, Politico reports that some state officials worry that if the individual mandate is struck down, healthy people could avoid buying policies and premiums for everyone else could skyrocket, putting them in a bind.
A growing risk of outbreaks of measles, pertussis, and other vaccine-preventable diseases in countries affected by Ebola must be countered by urgent scaling up of routine immunization activities, according to the World Health Organization.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
Researchers have developed a new analytical tool for medical applications and biological research that might be used to diagnose cancer more rapidly than conventional methods.
› Verified 4 days ago
| Provider Name | Farah Siddiqui |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1194988279 PECOS PAC ID: 2860665171 Enrollment ID: I20230112002305 |
News Archive
Many experts believe state-level health exchanges are here to stay. However, Politico reports that some state officials worry that if the individual mandate is struck down, healthy people could avoid buying policies and premiums for everyone else could skyrocket, putting them in a bind.
A growing risk of outbreaks of measles, pertussis, and other vaccine-preventable diseases in countries affected by Ebola must be countered by urgent scaling up of routine immunization activities, according to the World Health Organization.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
Researchers have developed a new analytical tool for medical applications and biological research that might be used to diagnose cancer more rapidly than conventional methods.
› Verified 4 days ago
| Provider Name | Farzad Saleh |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1073962270 PECOS PAC ID: 1254766009 Enrollment ID: I20231122001457 |
News Archive
Many experts believe state-level health exchanges are here to stay. However, Politico reports that some state officials worry that if the individual mandate is struck down, healthy people could avoid buying policies and premiums for everyone else could skyrocket, putting them in a bind.
A growing risk of outbreaks of measles, pertussis, and other vaccine-preventable diseases in countries affected by Ebola must be countered by urgent scaling up of routine immunization activities, according to the World Health Organization.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
Researchers have developed a new analytical tool for medical applications and biological research that might be used to diagnose cancer more rapidly than conventional methods.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Progressive Feet Llc 6130 Oxon Hill Rd Ste 305, Oxon Hill, MD 20745-3168 Ph: (301) 567-5005 | Progressive Feet Llc 8565 Sudley Rd Ste B, Manassas, VA 20110-3864 Ph: (571) 428-2350 |
News Archive
Many experts believe state-level health exchanges are here to stay. However, Politico reports that some state officials worry that if the individual mandate is struck down, healthy people could avoid buying policies and premiums for everyone else could skyrocket, putting them in a bind.
A growing risk of outbreaks of measles, pertussis, and other vaccine-preventable diseases in countries affected by Ebola must be countered by urgent scaling up of routine immunization activities, according to the World Health Organization.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
Researchers have developed a new analytical tool for medical applications and biological research that might be used to diagnose cancer more rapidly than conventional methods.
› Verified 4 days ago
Battlefield Foot & Ankle Center, P.c. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 10654 Crestwood Dr, Manassas, VA 20109 Phone: 703-361-3668 | |
Bull Run Foot Clinic Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 8637 Mathis Ave, Manassas, VA 20110 Phone: 703-335-6890 | |
Vineela Ayyagari, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9017 Fletcher Farm Ct, Manassas, VA 20112 Phone: 703-398-7944 | |
Ricardo Bennett, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 8704 Rolling Rd, Manassas, VA 20110 Phone: 703-361-3132 Fax: 703-368-0291 | |
Manassas Foot Clinic Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 8704 Rolling Rd, Manassas, VA 20110 Phone: 703-361-3132 Fax: 703-368-0291 | |
Lisa Ann Beckinella, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 8577 Sudley Rd Ste A, Manassas, VA 20110 Phone: 703-368-7166 Fax: 703-368-5103 | |
Bruce Ira Vogel, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 8577 Sudley Rd, Manassas, VA 20110 Phone: 703-368-7166 Fax: 703-368-5103 |